A recent DailyMail article discussed a new advancement in diagnostics that aims to help the thousands of men affected by prostate cancer each year. A team of medics and physicians at Nottingham Trent University has developed a new blood test that can diagnose prostate cancer and determine the stage of it with 99% accuracy. Previous research showed that cancer causes changes in the immune system that can be traced in the blood. The new test identifies these alterations in the white blood cells, and categorizes the risk as either low, intermediate, or high.
New Blood Test Diagnoses Prostate Cancer
The test determines the stage of the cancer with 99% accuracy.
Aug 3, 2020
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
